IRIS Accounts Production v24.2.0.383 02008880 director 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh020088802023-06-30020088802024-06-30020088802023-07-012024-06-30020088802022-06-30020088802022-07-012023-06-30020088802023-06-3002008880ns15:EnglandWales2023-07-012024-06-3002008880ns14:PoundSterling2023-07-012024-06-3002008880ns10:Director12023-07-012024-06-3002008880ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3002008880ns10:SmallEntities2023-07-012024-06-3002008880ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3002008880ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3002008880ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3002008880ns10:FullAccounts2023-07-012024-06-3002008880ns10:OrdinaryShareClass12023-07-012024-06-3002008880ns10:RegisteredOffice2023-07-012024-06-3002008880ns5:CurrentFinancialInstruments2024-06-3002008880ns5:CurrentFinancialInstruments2023-06-3002008880ns5:ShareCapital2024-06-3002008880ns5:ShareCapital2023-06-3002008880ns5:RetainedEarningsAccumulatedLosses2024-06-3002008880ns5:RetainedEarningsAccumulatedLosses2023-06-3002008880ns5:LandBuildings2023-06-3002008880ns5:PlantMachinery2023-06-3002008880ns5:LandBuildings2023-07-012024-06-3002008880ns5:PlantMachinery2023-07-012024-06-3002008880ns5:LandBuildings2024-06-3002008880ns5:PlantMachinery2024-06-3002008880ns5:LandBuildings2023-06-3002008880ns5:PlantMachinery2023-06-3002008880ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-06-3002008880ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-3002008880ns5:DeferredTaxation2023-06-3002008880ns5:DeferredTaxation2023-07-012024-06-3002008880ns5:DeferredTaxation2024-06-3002008880ns10:OrdinaryShareClass12024-06-30
REGISTERED NUMBER: 02008880 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

CLINICON (U.K.) LIMITED

CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)






Contents of the Financial Statements
for the year ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CLINICON (U.K.) LIMITED

Company Information
for the year ended 30 June 2024







DIRECTOR: J A Clegg





REGISTERED OFFICE: Unit 3
Quoin Industrial Estate
Marlborough Road
Lancing
East Sussex
BN15 8AD





REGISTERED NUMBER: 02008880 (England and Wales)





ACCOUNTANTS: Plus Accounting
Chartered Accountants
Preston Park House
South Road
Brighton
East Sussex
BN1 6SB

CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Balance Sheet
30 June 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 13,947 2,948

CURRENT ASSETS
Stocks 85,806 81,980
Debtors 5 53,295 64,549
Cash at bank 57,358 67,010
196,459 213,539
CREDITORS
Amounts falling due within one year 6 (46,992 ) (48,288 )
NET CURRENT ASSETS 149,467 165,251
TOTAL ASSETS LESS CURRENT
LIABILITIES

163,414

168,199

PROVISIONS FOR LIABILITIES 7 (2,650 ) (583 )
NET ASSETS 160,764 167,616

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 160,664 167,516
SHAREHOLDERS' FUNDS 160,764 167,616

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 September 2024 and were signed by:





J A Clegg - Director


CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Notes to the Financial Statements
for the year ended 30 June 2024

1. STATUTORY INFORMATION

Clinicon (U.K.) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable net of VAT and trade discounts, and is recognised as follows:

Revenue from the sale of medical equipment is recognised at the point of despatch.

Tangible fixed assets
Tangible fixed assets are stated at cost, or deemed cost, less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended by management.

Plant & machinery-25% on cost
Fixtures & fittings-25% on cost
Motor vehicles-25% reducing balance
Computer equipment-33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Notes to the Financial Statements - continued
for the year ended 30 June 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The director has a reasonable expectation that the company has adequate resources to continue in existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Impairment
At each balance sheet date, the company reviews the carrying amount of its assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of an asset, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Notes to the Financial Statements - continued
for the year ended 30 June 2024

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 July 2023 4,620 127,721 132,341
Additions - 14,174 14,174
Disposals - (39,867 ) (39,867 )
At 30 June 2024 4,620 102,028 106,648
DEPRECIATION
At 1 July 2023 4,620 124,773 129,393
Charge for year - 3,175 3,175
Eliminated on disposal - (39,867 ) (39,867 )
At 30 June 2024 4,620 88,081 92,701
NET BOOK VALUE
At 30 June 2024 - 13,947 13,947
At 30 June 2023 - 2,948 2,948

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 51,278 52,282
Other debtors 2,017 12,267
53,295 64,549

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 34,138 30,379
Taxation and social security 10,907 16,104
Other creditors 1,947 1,805
46,992 48,288

7. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 2,650 583

Deferred
tax
£   
Balance at 1 July 2023 583
Provided during year 2,067
Balance at 30 June 2024 2,650

CLINICON (U.K.) LIMITED (REGISTERED NUMBER: 02008880)

Notes to the Financial Statements - continued
for the year ended 30 June 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100